TrueBinding, Inc.
Santa Clara, CA, US· latest recorded location
TrueBinding, Inc. is named on 5 US grants and 17 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).
- Granted patents
- 5
- Published applications
- 17
- Inventors
- 27
- Granted in 2026 so far
- 0
- Most recent grant
- 16 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2021 | 0 | 3 |
| 2022 | 1 | 4 |
| 2023 | 1 | 2 |
| 2024 | 0 | 2 |
| 2025 | 3 | 4 |
| 2026 | 0 | 2 |
By publication year. 2026 runs to 8 Oct.
Technology areas
Share of 22 documents
Recent patents
- Anti-GAL3 antibodies and uses thereof16 Dec 2025US 12,497,458 B2
- Methods of treating inflammatory diseases by blocking Galectin-322 Apr 2025US 12,281,166 B2
- Treating cancer by blocking the interaction of TIM-3 and its ligand18 Feb 2025US 12,227,567 B2
- Treating cancer by blocking the interaction of TIM-3 and its ligand22 Aug 2023US 11,732,039 B2
- Anti-Gal3 antibodies and uses thereof30 Aug 2022US 11,427,638 B2
- Therapies with anti-gal3 antibodies27 Aug 2026US 2026/0250396 A1
- Anti-gal3 antibodies and uses thereof13 Aug 2026US 2026/0234269 A1
- Methods of treating inflammatory diseases by blocking galectin-331 Jul 2025US 2025/0243282 A1
- Treating cancer by blocking the interaction of tim-3 and its ligand29 May 2025US 2025/0171539 A1
- Anti-gal3 antibodies and methods of use8 May 2025US 2025/0145722 A1
Most cited
By later US patents